|
1
|
Dimou J and Kelly J: The biological and
clinical basis for early referral of low grade glioma patients to a
surgical neuro-oncologist. J Clin Neurosci. 78:20–29.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Liu M and Wang L: Prognostic significance
of preoperative serum albumin, albumin-to-globulin ratio, and
prognostic nutritional index for patients with glioma: A
meta-analysis. Medicine (Baltimore). 99(e20927)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Huang J, Yu J, Tu L, Huang N, Li H and Luo
Y: Isocitrate dehydrogenase mutations in glioma: From basic
discovery to therapeutics development. Front Oncol.
9(506)2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhang X, Zhao L, Zhai G, Ji J and Liu A:
Erratum: Multifunctional polyethylene glycol (PEG)-Poly
(Lactic-Co-Glycolic Acid) (PLGA)-based nanoparticles loading
doxorubicin and tetrahydrocurcumin for combined chemoradiotherapy
of glioma. Med Sci Monit. 26(e926333)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Finck T, Gempt J, Krieg SM, Meyer B,
Zimmer C, Wiestler B, Kirschke JS and Sollmann N: Assessment of the
extent of resection in surgery of high-grade glioma-evaluation of
black blood sequences for intraoperative magnetic resonance imaging
at 3 tesla. Cancers (Basel). 12(1580)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Opoku-Darko M, Lang ST, Artindale J,
Cairncross JG, Sevick RJ and Kelly JJP: Surgical management of
incidentally discovered diffusely infiltrating low-grade glioma. J
Neurosurg. 129:19–26. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Pisapia DJ: The updated World Health
Organization glioma classification: Cellular and molecular origins
of adult infiltrating gliomas. Arch Pathol Lab Med. 141:1633–1645.
2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
de Blank P, Fouladi M and Huse JT:
Molecular markers and targeted therapy in pediatric low-grade
glioma. J Neurooncol. 150:5–15. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Yan C, Wang J, Yang Y, Ma W and Chen X:
Molecular biomarker-guided anti-angiogenic targeted therapy for
malignant glioma. J Cell Mol Med. 23:4876–4882. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li J, Chai Z, Lu J, Xie C, Ran D, Wang S,
Zhou J and Lu W: αvβ3-targeted liposomal drug
delivery system with attenuated immunogenicity enabled by linear
pentapeptide for glioma therapy. J Control Release. 322:542–554.
2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
He Y, Wu C, Duan J, Miao J, Ren H and Liu
J: Anti-Glioma effect with targeting therapy using folate modified
nano-micelles delivery curcumin. J Biomed Nanotechnol. 16:1–13.
2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ye L, Zhang Y, Chen YJ and Liu Q:
Anti-tumor effects of lidocaine on human gastric cancer cells in
vitro. Bratisl Lek Listy. 120:212–217. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li YC, Wang Y, Li DD, Zhang Y, Zhao TC and
Li CF: Procaine is a specific DNA methylation inhibitor with
anti-tumor effect for human gastric cancer. J Cell Biochem.
119:2440–2449. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zuckerman LM, Frames WL, Mirshahidi HR,
Williams NL, Shields TG, Otoukesh S and Mirshahidi S:
Antiproliferative effect of bupivacaine on patient-derived sarcoma
cells. Mol Clin Oncol. 13(7)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Unami A, Shinohara Y, Ichikawa T and Baba
Y: Biochemical and microarray analyses of bupivacaine-induced
apoptosis. J Toxicol Sci. 28:77–94. 2003.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhao Y, Zhang L, Peng Y, Yue QM, Hai L,
Guo L, Wang QT and Wu Y: GLUT1-mediated
venlafaxine-thiamine disulfide system-glucose conjugates with
‘lock-in’ function for central nervous system delivery. Chem Biol
Drug Des. 91:707–716. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tsou YH, Zhang XQ, Zhu H, Syed S and Xu X:
Drug Delivery to the brain across the blood-brain barrier using
nanomaterials. Small. 13(e1701921)2017.PubMed/NCBI View Article : Google Scholar : Erratum in: Small
14, e1801588, 2018.
|
|
18
|
Yang Y, Zhao Z, Xie C and Zhao Y:
Dual-targeting liposome modified by glutamic hexapeptide and folic
acid for bone metastatic breast cancer. Chem Phys Lipids.
228(104882)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Akal ZU, Alpsoy L and Baykal A:
Superparamagnetic iron oxide conjugated with folic acid and
carboxylated quercetin for chemotherapy applications. Ceram Int.
42:9065–9072. 2016.
|
|
20
|
Zhao Z, Chen C, Xie C and Zhao Y: Design,
synthesis and evaluation of liposomes modified with dendritic
aspartic acid for bone-specific targeting. Chem Phys Lipids.
226(104832)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhao Z, Zhao Y, Xie C, Chen C, Lin D, Wang
S, Lin D, Cui X, Guo Z and Zhou J: Dual-active targeting liposomes
drug delivery system for bone metastatic breast cancer: Synthesis
and biological evaluation. Chem Phys Lipids.
223(104785)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Su Z, Xing L, Chen Y, Xu Y, Yang F, Zhang
C, Ping Q and Xiao Y: Lactoferrin-Modified Poly(ethylene
glycol)-Grafted BSA nanoparticles as a dual-targeting carrier for
treating brain gliomas. Mol Pharm. 11:1823–1834. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhang Y, Jia J, Jin W, Cao J, Fu T, Ma D
and Zhang Y: Lidocaine inhibits the proliferation and invasion of
hepatocellular carcinoma by downregulating USP14 induced PI3K/Akt
pathway. Pathol Res Pract. 216(152963)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Habimana-Griffin L, Ye D, Carpenter J,
Prior J, Sudlow G, Marsala L, Mixdorf M, Rubin J, Chen H and
Achilefu S: Intracranial glioma xenograft model rapidly
reestablishes blood-brain barrier integrity for longitudinal
imaging of tumor progression using fluorescence molecular
tomography and contrast agents. J Biomed Opt. 25:1–13.
2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Du J, Zhang L, Ma H, Wang Y and Wang P:
Lidocaine suppresses cell proliferation and aerobic glycolysis by
regulating circHOMER1/miR-138-5p/HEY1 axis in colorectal cancer.
Cancer Manag Res. 12:5009–5022. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Siekmann W, Tina E, Von Sydow AK and Gupta
A: Effect of lidocaine and ropivacaine on primary (SW480) and
metastatic (SW620) colon cancer cell lines. Oncol Lett. 18:395–401.
2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhou D, Wang L, Cui Q, Iftikhar R, Xia Y
and Xu P: Repositioning lidocaine as an anticancer drug: The role
beyond anesthesia. Front Cell Dev Biol. 8(565)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Suzuki S, Mori A, Fukui A, Ema Y and
Nishiwaki K: Lidocaine inhibits vascular endothelial growth
factor-A-induced angiogenesis. J Anesth. 34:857–864.
2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Sun H and Sun Y: Lidocaine inhibits
proliferation and metastasis of lung cancer cell via regulation of
miR-539/EGFR axis. Artif Cells Nanomed Biotechnol. 47:2866–2874.
2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Cierniak S, Koktysz R, Jesiotr M,
Gasowska-Bodnar A and Bodnar L: Expression of the PI3K/AKT/mTOR
pathway as a prognostic factor in patients with advanced high grade
serous ovarian carcinoma treated with neoadjuvant chemotherapy. Eur
J Gynaecol Oncol. 40:744–751. 2019.
|
|
31
|
Zuo X, Li L and Sun L: Plantamajoside
inhibits hypoxia-induced migration and invasion of human cervical
cancer cells through the NF-κB and PI3K/akt pathways. J Recept
Signal Transduct Res. 41:339–348. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Xiao Y, Deng T and Wang D: Davanone
terpenoid inhibits cisplatin-resistant acute myeloid leukemia
cancer cell growth by inducing caspase-dependent apoptosis, loss of
mitochondrial membrane potential, inhibition of cell migration and
invasion and targeting PI3K/AKT/MAPK signalling pathway. J BUON.
25:1607–1613. 2020.PubMed/NCBI
|
|
33
|
Liu Z, Mo H, Sun L, Wang L, Chen T, Yao B,
Liu R, Niu Y, Tu K, Xu Q and Yang N: Long noncoding RNA
PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular
carcinoma by activating PI3K/AKT/mTOR signaling pathway. Cancer
Sci. 111:4118–4128. 2020.PubMed/NCBI View Article : Google Scholar
|
